Literature DB >> 10544942

A possible solution to the paradox of the "lupus anticoagulant": antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V.

J H Rand, X X Wu, P Giesen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544942

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  The pathogenic role of annexin-V in the antiphospholipid syndrome.

Authors:  J H Rand
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

2.  Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Pojen P Chen; Keith R McCrae; Edwin G Bovill; Douglas J Taatjes
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

3.  Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Pojen P Chen; James J Hathcock; Douglas J Taatjes
Journal:  Blood       Date:  2008-06-24       Impact factor: 22.113

4.  Proteomics analysis of differentially expressed proteins in chicken trachea and kidney after infection with the highly virulent and attenuated coronavirus infectious bronchitis virus in vivo.

Authors:  Zhongzan Cao; Zongxi Han; Yuhao Shao; Xiaoli Liu; Junfeng Sun; Demin Yu; Xiangang Kong; Shengwang Liu
Journal:  Proteome Sci       Date:  2012-03-31       Impact factor: 2.480

Review 5.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.